文献速递脑血管病外科神经重症

再出血独立于迟发性脑缺血导致动脉瘤性蛛网膜下腔出血不良预后

Rebleeding drives poor outcome in aneurysmal subarachnoid hemorrhage independent of delayed cerebral ischemia: a propensity-score matched cohort study.
PubMed 文献 · J Neurosurg · 2019-07-19

倾向性评分匹配后仅不良功能结局与整体脑水肿仍与再出血显著相关;多因素回归显示再出血(HR 21.5)与DCI(HR 10.1)均独立预测不良功能结局,早期再出血未显著影响迟发性缺血并发症风险。

要点

  • 再出血与DCI均独立预测aSAH不良功能结局,再出血HR 21.5、DCI HR 10.1。
  • 匹配后仅不良功能结局与整体脑水肿仍与再出血显著相关。
  • 早期再出血未显著增加迟发性缺血并发症风险。

核心结论

  • 再出血与DCI对aSAH整体功能结局具有独立的负面影响。
  • 早期再出血未显著影响迟发性缺血并发症的发生风险。

研究设计与样本

  • 2001至2016年期间所有aSAH患者的队列研究。
  • 对危险因素与治疗方式行倾向性评分匹配,匹配后再出血组与非再出血组各43例。
  • 在匹配队列中行单因素与多因素有序logistic回归分析功能结局的预测因素。

主要发现

  • 总体队列中再出血与显著更差的功能结局、更长ICU住院时间及整体脑水肿相关(均p < 0.01)。
  • 总体队列中治疗方式、总住院时间、DCI、伴梗死DCI及症状性血管痉挛与再出血无显著关联。
  • 匹配分析中仅不良功能结局(p < 0.01)与整体脑水肿(p = 0.02)仍与再出血显著相关。
  • 多因素回归显示再出血(HR 21.5,p < 0.01)与DCI(HR 10.1,p = 0.01)均独立预测不良功能结局。

临床怎么用

  • aSAH患者应重视再出血的预防,因其独立且强烈预测不良功能结局。
  • DCI与再出血对预后影响独立,临床需同时关注两类事件。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Delayed cerebral ischemia (DCI) and aneurysm rebleeding contribute to morbidity and mortality in aneurysmal subarachnoid hemorrhage (aSAH); however, the relationship between their impacts on overall functional outcome is incompletely understood. METHODS: The authors conducted a cohort study of all aSAH during the study period from 2001 to 2016. Primary end points were overall functional outcome and ischemic aSAH sequelae, defined as delayed cerebral ischemia (DCI), DCI with infarction, symptomatic vasospasm (SV), and global cerebral edema (GCE). Outcomes were compared between the rebleed and nonrebleed cohorts overall and after propensity-score matching (PSM) for risk factors and treatment modality. Univariate and multivariate ordered logistic regression analyses for functional outcomes were performed in the PSM cohort to identify predictors of poor outcome. RESULTS: Four hundred fifty-five aSAH cases admitted within 24 hours of aneurysm rupture were included, of which 411 (90%) experienced initial aneurysm ruptures only, while 44 (10%) had clinically confirmed rebleeding. In the overall cohort, rebleeding was associated with significantly worse functional outcome, longer intensive care unit length of stay (LOS), and GCE (all p < 0.01); treatment modality, overall LOS, DCI, DCI with infarction, and SV were nonsignificant. In the PSM analysis of 43 matched rebleed and 43 matched nonrebleed cases, only poor functional outcome and GCE remained significantly associated with rebleeding (p < 0.01 and p = 0.02, respectively). Multivariate regression identified that both rebleeding (HR 21.5, p < 0.01) and DCI (HR 10.1, p = 0.01) independently predicted poor functional outcome. CONCLUSIONS: Rebleeding and DCI after aSAH are highly morbid and potentially deadly events after aSAH, which appear to have independent negative impacts on overall functional outcome. Early rebleeding did not significantly affect the risk of delayed ischemic complications.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Lu VM, Graffeo CS, Perry A, et al. Rebleeding drives poor outcome in aneurysmal subarachnoid hemorrhage independent of delayed cerebral ischemia: a propensity-score matched cohort study. J Neurosurg. 2019. PMID: 31323638. doi:10.3171/2019.4.JNS19779

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。